{
    "clinical_study": {
        "@rank": "55151", 
        "arm_group": {
            "arm_group_label": "Overfeeding", 
            "arm_group_type": "Experimental", 
            "description": "We overfed 40 young, healthy adults by 40% of their baseline energy requirements for 8 weeks.  The diet consisted of 41% carbohydrate, 44% fat, and 15% protein."
        }, 
        "brief_summary": {
            "textblock": "It has been shown that large fat cells are associated with more risks for insulin resistance\n      and more cardiovascular risk factors such as high cholesterol or triglycerides."
        }, 
        "brief_title": "Fat Cell Size and Overfeeding", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Over Eating", 
        "condition_browse": {
            "mesh_term": "Hyperphagia"
        }, 
        "detailed_description": {
            "textblock": "This study will look at fat cell size and how it affects fat deposition, insulin resistance\n      and muscle oxidative capacity.  A comparison will be made with the differences between\n      participants with larger versus smaller fat cells in insulin resistance and blood levels of\n      lipids. The study will also determine if characteristics of fat cells and muscle can predict\n      the development of weight gain-induced insulin resistance."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Your Body Mass Index (height to weight ratio) is 22.5 to 32.5 (inclusive).\n\n          -  You are 18-40 years of age.\n\n          -  You are willing to enroll in an 8 week overfeeding study causing a 5-8 % weight gain.\n\n          -  You are willing to eat all your meals from Pennington and only meals from Pennington\n             for approximately 10 weeks total, even when you are full.  Prior to overfeeding 2\n             Meals per day will be served at Pennington with lunch packed for at least 7 days.\n             After that time participants will receive and eat all (overfeeding) meals at PBRC for\n             8 weeks.  Post-overfeeding will consists of weight-maintenance diet for 1 week. All\n             meals will be monitored at Pennington.\n\n          -  You are willing to maintain the same level of exercise after enrollment in the study\n             throughout the length of the study.\n\n          -  You are willing to complete nutritional and activity questionnaires.\n\n        Exclusion Criteria:\n\n          -  You weight > 300 lbs\n\n          -  You have a history of cardiovascular disease or diabetes.\n\n          -  You have a fasting blood glucose > 110 mg/dL.\n\n          -  You have an average screening blood pressure > 140/90.\n\n          -  You have liver disease.\n\n          -  You have thyroid disease.\n\n          -  Have Acid Reflux\n\n          -  Had cancer in the last 5 years (Some skin cancers OK)\n\n          -  Have HIV\n\n          -  Have had an Eating Disorders\n\n          -  You are pregnant or breastfeeding.\n\n          -  You have gained or lost more than 3kg in the last 3 months\n\n          -  You require chronic use of medications including diuretics, steroids and\n             adrenergic-stimulating agents.\n\n          -  You or a member of your family has a history of blood clots (deep vein thrombosis or\n             pulmonary embolism)\n\n          -  You have poor circulation, history of bypass operation in your legs, blood\n             coagulation disorders, diagnosed peripheral arterial or vascular disease, cramping\n             pain in your leg muscle during exercise or nerve damage to your legs\n\n          -  You have varicose veins (per discretion of MD or NP)\n\n          -  You have had previous GI surgery, obstructive disease of the GI tract, hyper motility\n             disorder or a history of problems of impairment of the gag reflex.\n\n          -  You have emotional problems such as clinical depression or other diagnosed\n             psychological conditions.\n\n          -  You are claustrophobic.\n\n          -  You have metal objects in your body such as implanted rods or surgical clips or\n             magnetic objects that are incompatible with the MRI/MRS.\n\n          -  You smoke or use tobacco products"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01672632", 
            "org_study_id": "EAT  PBRC26040"
        }, 
        "intervention": {
            "arm_group_label": "Overfeeding", 
            "description": "We overfed 40 young, healthy adults by 40% of their baseline energy requirements for 8 weeks.  The diet consisted of 41% carbohydrate, 44% fat, and 15% protein.", 
            "intervention_name": "Overfeeding", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Baton Rouge", 
                    "country": "United States", 
                    "state": "Louisiana", 
                    "zip": "70808"
                }, 
                "name": "Pennington Biomedical Research Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Fat Cell Size and Overfeeding and Etopic Study", 
        "overall_official": [
            {
                "affiliation": "Pennington Biomedical Research Center", 
                "last_name": "Eric Ravussin, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Pennington Biomedial Research Center", 
                "last_name": "Alok Gupta, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "This study will investigate how fat cell size (independent of total fat mass) affects metabolic outcomes of overfeeding, including changes in fat deposition, insulin sensitivity and muscle oxidative capacity.  It has been shown that large fat cells relative to fat mass are associated with higher risks for insulin resistance and type 2 diabetes.", 
            "measure": "Determine the effect of 8-weeks 40% high fat overfeeding in 40 healthy, young adults on adipose and skeletal muscle characteristics, ectopic fat accumulation, insulin sensitivity, and metabolic flexibility.", 
            "safety_issue": "No", 
            "time_frame": "10 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01672632"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Pennington Biomedical Research Center", 
            "investigator_full_name": "Eric Ravussin", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Viewing of adipose tissue or body fat and skeletal muscle characteristics over a period.", 
                "measure": "Fat Deposition", 
                "safety_issue": "No", 
                "time_frame": "10 Months"
            }, 
            {
                "description": "Measure and monitor the natural hormone insulin becomes less effective at lowering blood sugars. The resulting increase in blood glucose may raise levels outside the normal range and cause adverse heealth effects, depending on dietary conditions or sensitivity of cells to insulin.", 
                "measure": "Insulin Sensitivity", 
                "safety_issue": "No", 
                "time_frame": "10 months"
            }, 
            {
                "description": "A measure of a muscle's maximal capacity to use oxygen in microliters of oxygen consumed per gram of muscle per hour.", 
                "measure": "Muscle Oxidative Capacity", 
                "safety_issue": "No", 
                "time_frame": "10 Months"
            }, 
            {
                "description": "Blood pressure and heart rate measurement: An automatic BP monitoring device (Mortara\u00ae Ambulo 2400) for ambulatory use was attached to a BP cuff to obtain blood pressure (BP) and heart rate (HR) readings at 30-min intervals during the day (6:30 AM to 9:30 PM) and 60-min intervals at night (10 PM to 6 AM) while the participants went about their activities. Data were downloaded into the database at the end of the 7-day recording span for a chronobiological analysis. This was done at baseline, post-overfeeding and at 3 months.", 
                "measure": "Circadian Blood Pressure variability", 
                "safety_issue": "No", 
                "time_frame": "10 Months"
            }, 
            {
                "description": "Endothelial function testing: Assessment of resting endothelial function was done with the participant in a fasting state, after having avoided stimulants (caffeine, tobacco, alcohol, exercise) for 12 hours, at the same fixed clock hour (range 8-10 AM), using the EndoPAT 2000 device manufactured by ITAMAR Medical\u00ae.", 
                "measure": "Resting Endothelial function testing", 
                "safety_issue": "No", 
                "time_frame": "10 Months"
            }
        ], 
        "source": "Pennington Biomedical Research Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Pennington Biomedical Research Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2008", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}